CYP 2021 - The year ahead, page-465

In reply to @Pledge

"It is not unusual for drug development to take about 10 years to get from a lab bench to hospital ward, he said. "These things always take longer and cost more money than you anticipated in the beginning but the value of a platform technology is that you are not a one-trick pony," Dr Itescu said."
https://www.copyright link/companies/healthcare-and-fitness/mesoblast-shares-plunge-25pc-as-teva-withdraws-from-heart-failure-trials-20160614-gpief8

10 years from lab bench to hospital ward, I see. You acquired Prochymal during a P3 trial in... when exactly? P3 is not lab bench, is it? Now I'm adding 10 years to an acquisition of a product that was in a P3 trial at the time (not lab bench) and according to SI we are in the hospital wards by when? Sorry, my maths is not great, but are we getting good vibes reading this?

Remember when you were funny and original? Big dxck syndrome at its finest. Pointing at past CEO statements of Cynata and investing in MSB statements like the above. Come one, lets keep going and find out which company has had the most missed timelines and made more statements that haven't been kept. Show me how superior your investment is because from where I'm standing, both have been pretty pxxx poor.